Gayle Campbell, MA, CCC, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 667 Hopewell Drive, Heath, OH 43056 Phone: 740-344-6557 Fax: 740-522-4634 |
Chris Glaviano Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 680 S 30th St, Heath, OH 43056 Phone: 740-522-4801 |
Ashley Marie Lindvall, MA, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 667 Hopewell Dr, Heath, OH 43056 Phone: 740-344-6557 Fax: 740-522-4634 |
News Archive
For patients diagnosed with a Staphylococcus aureus infection, often referred to as a staph or MRSA infection, every minute counts.
High school graduates have more in common with newborn babies than one would think. Although departing the proverbial family nest, incoming college freshmen need vaccinations, too.
ZyStor Therapeutics, Inc., a biotechnology company developing a new class of targeted protein therapeutics for the treatment of Lysosomal Storage Diseases using the Company's proprietary Glycosylation Independent Lysosomal Targeting technology, today announced that it has received clearance from the U. S. Food and Drug Administration to proceed into a clinical trial for its first drug candidate, ZC-701, an enzyme replacement therapy for the treatment of Pompe disease.
NUST MISIS scientists jointly with their colleagues from the Ecole de Technologie Superiore have experienced a new combination of alloy processing that produces solid and durable implants that are fully compatible with the human body. The research article is published in the Journal of Alloys and Compounds.
› Verified 5 days ago